Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 5, 1999

View Archived Issues

Atugen and Roche Bioscience enter target validation collaboration

Radicicol derivative depletes Hsp90-associated molecules, exhibits antitumor activity

King Pharmaceuticals to acquire Lorabid from Lilly

GAD65 peptides prevent diabetes in mouse model

Inhibitex awarded SBIR grant to develop vaccine against drug-resistant infections

ROCK inhibitor Y-27632 affects ET-1-induced hypertrophy in rat cardiac myocytes

Ivax completes tender offer for outstanding shares of Galena

Genelabs Technologies: Q2 1999 highlights

Patent for wound healing technology patent awarded to BioSpecifics and Tufts

Merck launches COX-2 inhibitor in the U.K.

Corixa highlights collaborative agreements established in Q2 1999

Cangene to acquire Hyal

Promising troponin I analogue identified

Phase I trial begins for SMART 1D10 antibody in non-Hodgkin's B-cell lymphoma

First launch for bile acid-sequestering agent colestimide

Guilford and Amgen begin clinical testing of neuroimmunophilins

PDGFr-TK inhibitor prevents restenosis following angioplasty in minipigs

Diatide receives second major product approval in less than 12 months

NIH researchers identify potential clue to the prevention of prion diseases

U.K.'s MCA is first to approve Synercid for marketing

Indian academic team identifies interesting new antibacterial compounds

Novel AMPA/NMDA antagonists discovered at Rhone-Poulenc Rorer

INSERM describes TPP II inhibitors and their use in treating eating disorders, obesity

SB team identifies bone resorption inhibitors selective for mammalian osteoclasts

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...